SUPN — Supernus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Supernus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	347	423	340	461	255
Net Total Accounts Receivable
Net Total Receivables	87.3	141	149	165	144
Total Inventory
Prepaid Expenses
Total Current Assets	473	630	602	734	493
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38.3	58.1	52.3	44.1	42.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,160	1,504	1,689	1,703	1,278
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	161	245	315	688	290
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	565	759	873	816	356
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	595	745	816	886	922
Total Liabilities & Shareholders' Equity	1,160	1,504	1,689	1,703	1,278
Total Common Shares Outstanding